Lacerta Bio at AAPS Chicago
Next week, Lacerta Bio will be at the AAPS Annual Meeting in Chicago. If you have plans to attend, drop us a note! To follow the action on Twitter, use…
Menu
Compounding Pharmacists & NECC
When we studied pharmacy, compounding was in integral part of our education. On a weekly basis, we compounded just about everything: creams, lotions, elixirs, suspensions, parenterals, capsules (by hand), etc.,…
But who will pay?
An intriguing graph was posted on Twitter the other day: Now we understand the argument, and it's a good one: As the population ages, there will be more long-term illness,…
More Me-Too Products, Not Fewer
An article by our good friend Derek Hennecke in the September issue of Drug Development & Delivery really struck a nerve with us...but in a good way. To quote (with…
Pharma Competitive Intelligence, Then and Now
Pharmaceutical and biotech competitive intelligence is increasingly important and challenging these days. Lacerta Bio discusses a recent case study in which a client learned this the hard way.
Lacerta Bio at BIO-Europe 2012 in Hamburg
Lacerta Bio is pleased to announce our attendance at the upcoming BIO-Europe 2012 conference in Hamburg, Germany. In our view, the Fall version of BIO-Europe is the premier partnering…
Abandon R&D for M&A? Vote today!
In response to the recent acquisition of Medicis by Valeant, an interesting poll underway asking a seemingly simple question, "Will other pharma companies follow Valeant and abandon R&D in favor…
Need international out-licensing help?
At Lacerta Bio, we're in the middle of several international out-licensing projects. This process is enabling us to re-connect with many companies around the world. In addition, we're making new…
LLC may be better than C corp
We generally agree with the notion that many early-stage biotechs should be structured as LLCs instead of C corps. This short interview with Attorney Albert L. Sokol highlights one key…
Venture Financing: Is China the answer?
As we read the continuing bad news regarding venture financing in biotech, we came across this bit of news from the UK: BioCity Nottingham-based CompanDX Limited, the Nottingham Trent University…
- Go to the previous page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- …
- 32
- Go to the next page